Pachel, C., Mathes, D., Bayer, B., Dienesch, C., Wangorsch, G., Heitzmann, W., . . . Frantz, S. (2013). Exogenous administration of a recombinant variant of TWEAK impairs healing after myocardial infarction by aggravation of inflammation. Public Library of Science (PLoS).
Cita Chicago Style (17a ed.)Pachel, Christina, et al. Exogenous Administration of a Recombinant Variant of TWEAK Impairs Healing After Myocardial Infarction by Aggravation of Inflammation. Public Library of Science (PLoS), 2013.
Cita MLA (8a ed.)Pachel, Christina, et al. Exogenous Administration of a Recombinant Variant of TWEAK Impairs Healing After Myocardial Infarction by Aggravation of Inflammation. Public Library of Science (PLoS), 2013.
Precaución: Estas citas no son 100% exactas.